At 7.6% CAGR, Nuclear Medicine Market Size will reach 6610 million USD by 2024

A detailed study on ‘Nuclear Medicine market’ formulated by Market Study Report, LLC, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry’s size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in the projection timeline, while including their expansion strategies and portfolio.

The worldwide market for Nuclear Medicine is expected to grow at a CAGR of roughly 7.6% over the next five years, will reach 6610 million US$ in 2023, from 4590 million US$ in 2017, according to a new study.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/1155702?utm_source=B&F.com-Abhijeet

Market Segment by Manufacturers, this report covers

  • GE Healthcare
  • Bracco Imaging
  • Mallinckrodt
  • Lantheus Medical Imaging
  • Bayer
  • Triad Isotopes
  • Nordion
  • Jubilant Pharma
  • Eli Lilly
  • SIEMENS
  • China Isotope & Radiation
  • Dongcheng

Nuclear Medicineor Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

This report focuses on the Nuclear Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.

The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/1155702?utm_source=B&F.com-Abhijeet

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Tc-99

I-123/131

In-111

Xe-133

Th-201

Ga-67

Other

Market Segment by Applications, can be divided into

Diagnostic

Therapeutic

There are 15 Chapters to deeply display the global Nuclear Medicine market.

Chapter 1, to describe Nuclear Medicine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Nuclear Medicine, with sales, revenue, and price of Nuclear Medicine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Nuclear Medicine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Nuclear Medicine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Nuclear Medicine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

2 Manufacturers Profiles

3 Global Nuclear Medicine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

4 Global Nuclear Medicine Market Analysis by Regions

5 North America Nuclear Medicine by Countries

6 Europe Nuclear Medicine by Countries

7 Asia-Pacific Nuclear Medicine by Countries

8 South America Nuclear Medicine by Countries

9 Middle East and Africa Nuclear Medicine by Countries

10 Global Nuclear Medicine Market Segment by Type

11 Global Nuclear Medicine Market Segment by Application

12 Nuclear Medicine Market Forecast (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/1155702?utm_source=B&F.com-Abhijeet

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog